Beckman Coulter Recalls COULTER DxH Diluent Lots Due to Elevated Platelet Background Counts

Source: FDA · United States

According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.

Beckman Coulter, Inc. has issued a voluntary recall for over 76,000 units of COULTER DxH Diluent products due to issues with elevated platelet background counts during daily analyzer checks.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on February 17, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.

For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevice) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.

What Happened

Beckman Coulter, Inc. has initiated a voluntary recall of specific lots of COULTER DxH Diluent and COULTER DxH ECO Diluent. The recall was triggered after it was determined that certain lots contribute to elevated platelet "Daily Checks" background counts when used with cellular analyzers. This issue was identified as a Class II recall by the FDA.

Which Products Are Affected

The recall affects approximately 76,098 units (61,843 in the U.S. and 14,255 internationally). The affected products are used as isotonic buffered diluents for counting and sizing blood cells on UniCel DxH Coulter Cellular Analysis Systems and as rinsing agents on Slidemaker Stainers.

Product Details:

  • Product Names: COULTER DxH Diluent (REF 628017) and COULTER DxH ECO Diluent (REF C67250)
  • UDI-DI Code: 15099590233686
  • Recall Number: Z-1221-2026
  • Affected Lot Numbers: 2510410, 2510420, 2510450, 3557500, 3557510, 3557540, 3557560, 3557570, 3557640, 3557650, 3557660, 3557670, 3557680, 3557700, 3557710, 3557850, 3557920, 3557930, 3558000, 3558030, 3558040, 3558060, 3558090, 3558100, 3558110, 3558120, 3558140, 3558150, 3558160, 3558170.

Geographic Scope: Distribution was worldwide, including U.S. nationwide distribution in AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, WA, WI, and WV. International distribution included Argentina, Canada, Chile, Mexico, Saint Kitts and Nevis, Trinidad and Tobago, and Viet Nam.

What You Should Do

Beckman Coulter, Inc. notified affected customers via letter starting November 10, 2025. Laboratories and healthcare facilities should immediately check their inventory for the affected lot numbers listed above. For information regarding the return or replacement of affected products, customers should contact Beckman Coulter, Inc. at their Miami facility located at 11800 Sw 147th Ave, Miami, FL 33196-2500.

Why This Matters

Elevated background counts during daily checks can interfere with the accuracy of blood cell counting and sizing. This defect may lead to unreliable diagnostic results when using UniCel DxH Coulter Cellular Analysis Systems.

Source

Information provided by the FDA.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Beckman Coulter, Inc. has issued a voluntary recall for over 76,000 units of COULTER DxH Diluent products due to issues with elevated platelet background counts during daily analyzer checks.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.